Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
about
New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015–September 2015Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044.Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.
P2860
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic and biological sign ...... d with rituximab-CHOP therapy.
@en
type
label
Prognostic and biological sign ...... d with rituximab-CHOP therapy.
@en
prefLabel
Prognostic and biological sign ...... d with rituximab-CHOP therapy.
@en
P2093
P2860
P50
P1433
P1476
Prognostic and biological sign ...... d with rituximab-CHOP therapy.
@en
P2093
Andrés J M Ferreri
April Chiu
Ben M Parsons
Carlo Visco
Dennis P O'Malley
Eric D Hsi
Jane N Winter
Jooryung Huh
Karen Dybkær
Ken H Young
P2860
P2888
P304
P356
10.1038/MODPATHOL.2015.94
P50
P577
2015-08-07T00:00:00Z
P5875
P6179
1023632188